0001213900-22-049737.txt : 20220819 0001213900-22-049737.hdr.sgml : 20220819 20220819165513 ACCESSION NUMBER: 0001213900-22-049737 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220817 FILED AS OF DATE: 20220819 DATE AS OF CHANGE: 20220819 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SETH SANDESH CENTRAL INDEX KEY: 0001566175 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36374 FILM NUMBER: 221181431 MAIL ADDRESS: STREET 1: 300 E 93RD STREET, #20-B CITY: NEW YORK STATE: NY ZIP: 10128 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Actinium Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001388320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880378336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 275 MADISON AVENUE, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 646-677-3875 MAIL ADDRESS: STREET 1: 275 MADISON AVENUE, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: Cactus Ventures, Inc. DATE OF NAME CHANGE: 20070130 4 1 ownership.xml X0306 4 2022-08-17 0 0001388320 Actinium Pharmaceuticals, Inc. ATNM 0001566175 SETH SANDESH C/O ACTINIUM PHARMACEUTICALS, INC., 275 MADISON AVENUE, 7TH FLOOR NEW YORK, NY 10016 1 1 0 0 Chief Executive Officer Common Stock 2022-08-17 4 A 0 300000 0 A 305381 D /s/ Sandesh Seth 2022-08-19